Raissa Almeida
Researcher at the Federal University of Rio Grande do Norte (UFRN)
Papers
5 publications
Trials
0 clinical trials
Key Impact
Coauthor on multiple DMT clinical studies from the UFRN/Brain Medicine group, contributing to early human evidence on inhaled/vaporized DMT for depression and safety.
Background & Research
Raissa Almeida appears to be a Brazilian researcher affiliated with the Federal University of Rio Grande do Norte (UFRN) and the DMT clinical research team led by Draulio Araujo and collaborators. She is listed as a coauthor on several psychedelic research papers, including phase I/II studies of inhaled or vaporized N,N-dimethyltryptamine (DMT) and a study on psychedelic drug use and schizotypy in young adults.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Healthy VolunteersDepressive DisordersAnxiety DisordersTreatment-Resistant Depression (TRD)Safety & Risk ManagementMajor Depressive Disorder (MDD)SchizophreniaAdolescentsSuicidalityImplementation & Service DeliveryHealth Economics & ReimbursementPublic Health, Prevention & Behaviour ChangeSet & Setting